Clinic
Oktibbeha County Hospital
Oktibbeha County Hospital was paid $19.84M by Medicaid between Jan 2018 and Dec 2024, across 205 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoOKTIBBEHA COUNTY HOSPITAL
STARKVILLE, MS 39759
STARKVILLE, MS 39759
33aNPI1154310514assigned 10/18/2005
33bProvider typeSleep Disorder Diagnostic Clinic/Center
28Total paid$19.84M
24GClaims443,633
24DCodes billed205
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JACKSON, JAMES controls 11+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,436 | $3.31M | |
| 2019 | 72,566 | $3.50M | |
| 2020 | 62,581 | $2.44M | |
| 2021 | 66,903 | $2.77M | |
| 2022 | 66,007 | $3.00M | |
| 2023 | 57,359 | $2.84M | |
| 2024incomplete | 37,781 | $1.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 29,481 | 25,603 | $4.16M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 18,277 | 15,536 | $3.63M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 5,496 | 4,739 | $1.22M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.9% | 9,923 | 4,202 | $976K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.3% | 7,731 | 6,209 | $645K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 3,413 | 2,960 | $615K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 2.3% | 8,168 | 1,382 | $463K |
| G0378 | Hospital observation service, per hour | 2.2% | 1,415 | 1,204 | $443K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 4,926 | 4,374 | $414K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.1% | 11,523 | 9,299 | $410K |
| 59025 | Fetal non-stress test | 1.9% | 3,605 | 2,451 | $376K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 7,559 | 6,624 | $337K |
193 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 4,427 | $283K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 6,172 | $280K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 4,988 | $228K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 2,687 | $226K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 5,833 | $226K |
| 30140 | 1.0% | 149 | $200K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 2,358 | $199K |
| 31276 | <1% | 37 | $189K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,673 | $174K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,814 | $167K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 3,256 | $163K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,144 | $159K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,155 | $151K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 2,812 | $150K |
| 86900 | <1% | 2,411 | $143K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25,212 | $142K |
| 87430 | <1% | 10,641 | $135K | |
| 54161 | <1% | 107 | $132K | |
| 80053 | Comprehensive metabolic panel | <1% | 16,540 | $130K |
| D7210 | Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth | <1% | 387 | $129K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 815 | $121K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,084 | $111K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,716 | $107K |
| 31287 | <1% | 37 | $105K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,527 | $100K |
| 73560 | <1% | 2,005 | $78K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,329 | $74K |
| 73610 | <1% | 1,554 | $68K | |
| 73630 | <1% | 1,621 | $65K | |
| 86850 | <1% | 2,301 | $65K | |
| A0425 | Ground mileage, per statute mile | <1% | 2,391 | $63K |
| 31256 | <1% | 38 | $62K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 629 | $51K |
| 73030 | <1% | 1,227 | $49K | |
| 87077 | <1% | 3,323 | $45K | |
| 84703 | <1% | 7,691 | $45K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,111 | $44K |
| 86901 | <1% | 2,411 | $44K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,870 | $43K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,286 | $43K |
| 81001 | <1% | 19,153 | $42K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,293 | $39K |
| 70486 | <1% | 604 | $39K | |
| 76000 | <1% | 351 | $38K | |
| 73130 | <1% | 782 | $37K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 314 | $35K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 941 | $34K |
| 86756 | <1% | 2,591 | $33K | |
| 73502 | <1% | 930 | $32K | |
| 97161 | <1% | 877 | $32K | |
| 73110 | <1% | 606 | $29K | |
| 72100 | <1% | 465 | $27K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,493 | $26K |
| 83880 | <1% | 985 | $26K | |
| 97597 | <1% | 805 | $25K | |
| 84484 | <1% | 2,480 | $25K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 620 | $24K |
| 94060 | <1% | 308 | $24K | |
| 87186 | <1% | 2,957 | $23K | |
| 36600 | <1% | 607 | $20K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,590 | $18K |
| 74018 | <1% | 461 | $18K | |
| 83690 | <1% | 3,377 | $18K | |
| 80061 | Lipid panel | <1% | 1,712 | $18K |
| 73564 | <1% | 326 | $17K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 165 | $16K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 118 | $16K |
| 84702 | <1% | 1,303 | $15K | |
| 87070 | <1% | 1,985 | $14K | |
| 87590 | <1% | 713 | $14K | |
| 97113 | <1% | 323 | $14K | |
| 62323 | <1% | 83 | $14K | |
| 87075 | <1% | 1,715 | $13K | |
| 94726 | <1% | 160 | $13K | |
| 15271 | <1% | 30 | $13K | |
| 87490 | <1% | 715 | $12K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 474 | $12K |
| 94762 | <1% | 435 | $12K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 283 | $12K |
| 82248 | <1% | 2,713 | $12K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 31 | $11K |
| 82803 | <1% | 620 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,500 | $11K |
| 83874 | <1% | 999 | $11K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 115 | $11K |
| 97162 | <1% | 267 | $10K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 913 | $10K |
| 82150 | <1% | 1,791 | $9K | |
| 82247 | <1% | 1,965 | $9K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 133 | $9K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 165 | $9K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 843 | $8K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $7K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 300 | $7K |
| 92585 | <1% | 29 | $6K | |
| D1120 | Dental cleaning, child | <1% | 809 | $6K |
| 82375 | <1% | 608 | $6K | |
| 83020 | <1% | 656 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 121 | $5K |
| 82820 | <1% | 607 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 17 | $5K |
| 93925 | <1% | 68 | $5K | |
| D1206 | Topical application of fluoride varnish | <1% | 830 | $5K |
| 73140 | <1% | 87 | $5K | |
| 64493 | <1% | 14 | $5K | |
| 83735 | <1% | 877 | $4K | |
| 73590 | <1% | 95 | $3K | |
| 85730 | <1% | 732 | $3K | |
| 87040 | <1% | 260 | $3K | |
| 85610 | <1% | 1,008 | $3K | |
| 71250 | <1% | 77 | $3K | |
| 83050 | <1% | 606 | $3K | |
| 84100 | <1% | 855 | $3K | |
| 82962 | <1% | 1,194 | $2K | |
| 20610 | <1% | 25 | $2K | |
| 92652 | <1% | 15 | $2K | |
| 73090 | <1% | 47 | $2K | |
| 87210 | <1% | 630 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 27 | $2K |
| 73070 | <1% | 62 | $2K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $2K |
| 85378 | <1% | 266 | $2K | |
| 86922 | <1% | 19 | $2K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 213 | $2K |
| 82607 | <1% | 142 | $2K | |
| 11045 | <1% | 1,081 | $2K | |
| 82570 | <1% | 1,013 | $1K | |
| 83605 | <1% | 143 | $1K | |
| 72040 | <1% | 33 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $1K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 912 | $1K |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $925.38 |
| D2330 | <1% | 63 | $838.12 | |
| 90384 | <1% | 16 | $763.12 | |
| 93971 | <1% | 25 | $728.55 | |
| 83615 | <1% | 157 | $702.66 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $576.81 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $573.59 |
| 51701 | <1% | 12 | $520.14 | |
| 84550 | <1% | 149 | $495.25 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 39 | $462.57 |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 278 | $330.49 |
| 94664 | <1% | 3,930 | $305.10 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,439 | $303.64 |
| 85651 | <1% | 91 | $277.70 | |
| 0598T | <1% | 28 | $244.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,780 | $204.12 |
| 84156 | <1% | 150 | $174.43 | |
| 87205 | <1% | 96 | $165.12 | |
| J2704 | Injection, propofol, 10 mg | <1% | 6,029 | $158.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,850 | $123.35 |
| 82270 | <1% | 38 | $121.69 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,462 | $98.25 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,902 | $86.03 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 663 | $57.25 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,499 | $48.16 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,247 | $22.54 |
| 80320 | <1% | 68 | $20.86 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,710 | $6.56 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,076 | $2.78 |
| 96376 | 0% | 2,398 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 1,140 | $0.00 |
| 99402 | 0% | 69 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 2,248 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 316 | $0.00 |
| 36416 | 0% | 67 | $0.00 | |
| 61782 | 0% | 50 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 52 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 49 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 61 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 50 | $0.00 |
| 80050 | General health panel | 0% | 16 | $0.00 |
| 64494 | 0% | 12 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 30 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 17 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 505 | $0.00 |
| J2950 | Injection, promazine hcl, up to 25 mg | 0% | 793 | $0.00 |
| 90715 | 0% | 384 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 498 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 760 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 138 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 233 | $0.00 |
| 80323 | 0% | 805 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 42 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 312 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 108 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 98 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 232 | $0.00 |
| 94729 | 0% | 185 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 61 | $0.00 |
| C2625 | Stent, non-coronary, temporary, with delivery system | 0% | 38 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 31 | $0.00 |
| 99401 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJACKSON, JAMES (CEO)
| Provider | Location | Paid |
|---|---|---|
| Oktibbeha County Hospital | Starkville, MS | $1.91M |
| Och Center for Pain Management | Starkville, MS | $386K |
| Och Family Practice Ackerman | Ackerman, MS | $124K |
| Och Professional Services | Starkville, MS | $108K |
| Medcare Emergency Medical Services, INC. | Camden, AL | $104K |
| Och Pulmonology | Starkville, MS | $47K |
| Och Family Health Clinic | Starkville, MS | $29K |
| Och Medical Associates | Starkville, MS | $23K |
| Och General Surgery Associates | Starkville, MS | $6K |
| Jackson & Bigelow MD PC | Midland, MI | $884.56 |
| James Andrew Jackson, DDS, PLLC | Olive Branch, MS | $168.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.